Aids Research And Therapy

Aids Research And Therapy

艾滋病研究与治疗

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Aids Research And Therapy》是由BioMed Central出版社于2004年创办的英文国际期刊(ISSN: 1742-6405,E-ISSN: 1742-6405),该期刊长期致力于传染病学领域的创新研究,主要研究方向为INFECTIOUS DISEASES。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA开放获取模式(OA占比1%),以发表传染病学领域等方向的原创性研究为核心(研究类文章占比90.00%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在90篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Aids Research And Therapy审稿周期约为 16 Weeks 。该刊近年未被列入国际预警名单,年发文量约90篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 90 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
INFECTIOUS DISEASES 传染病学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
INFECTIOUS DISEASES 传染病学
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:INFECTIOUS DISEASES SCIE Q3 84 / 132

36.7%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:INFECTIOUS DISEASES SCIE Q3 90 / 132

32.2%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:3.8 SJR:0.872 SNIP:0.837
学科类别 分区 排名 百分位
大类:Medicine 小类:Pharmacology (medical) Q2 130 / 272

52%

大类:Medicine 小类:Virology Q3 49 / 80

39%

大类:Medicine 小类:Molecular Medicine Q3 120 / 178

32%

期刊发文

  • Camrelizumab for cancers in patients living with HIV: one-single center experience

    Author: Wu, Menghua; Zheng, Xin; Zhang, Yu; Song, Jian; Zhao, Jimao

    Journal: AIDS RESEARCH AND THERAPY. 2023; Vol. 20, Issue 1, pp. -. DOI: 10.1186/s12981-023-00518-y

  • Multi-dimensional mismatch and barriers for promoting PrEP among men who have sex with men in China: a cross sectional survey from the Demand-side

    Author: Guan, Yuan; Qi, Tangkai; Liao, Qibin; Zhang, Renfang; Chen, Jun; Liu, Li; Shen, Yinzhong; Zhu, Han; Tang, Qi; Lu, Hongzhou

    Journal: AIDS RESEARCH AND THERAPY. 2023; Vol. 20, Issue 1, pp. -. DOI: 10.1186/s12981-022-00497-6

  • Role of microglia in HIV-1 infection

    Author: Bai, Ruojing; Song, Chengcheng; Lv, Shiyun; Chang, Linlin; Hua, Wei; Weng, Wenjia; Wu, Hao; Dai, Lili

    Journal: AIDS RESEARCH AND THERAPY. 2023; Vol. 20, Issue 1, pp. -. DOI: 10.1186/s12981-023-00511-5

  • HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in Southwestern China: a large-scale cross-sectional study

    Author: Xi Hu, Bingyu Liang, Chongxing Zhou, Junjun Jiang, Jiegang Huang, Chuanyi Ning, Jie Liu, Bo Zhou, Ning Zang, Jinzhen Lai, Rongfeng Chen, Yanyan Liao, Peijiang Pan, Xin Liu, Guanghua Lan, Xianwu Pang, Li Ye, Zhiyong Shen, Hao Liang

    Journal: AIDS Research and Therapy, 2019, Vol.16, , DOI:10.1186/s12981-019-0221-7

  • Prophylactic and therapeutic effect of AZT/3TC in RT-SHIV infected Chinese-origin rhesus macaques

    Author: Wei Wang, Nan Yao, Zhe Cong, Hong Jiang, Chuan Qin, Qiang Wei

    Journal: AIDS Research and Therapy, 2014, Vol.11, 12, DOI:10.1186/1742-6405-11-12

  • Compare mDCs and pDCs between two distinct patients groups in acute HIV-1 infection

    Author: Yanmei Jiao, Xin Sun, Xiaojie Huang, Wei Li, Tong Zhang, Hao Wu

    Journal: AIDS Research and Therapy, 2014, Vol.11, 22, DOI:10.1186/1742-6405-11-22

  • The development of drug resistance mutations K103N Y181C and G190A in long term Nevirapine-containing antiviral therapy

    Author: Yuncong Wang, Hui Xing, Lingjie Liao, Zhe Wang, Bin Su, Quanbi Zhao, Yi Feng, Pengfei Ma, Jia Liu, Jianjun Wu, Yuhua Ruan, Yiming Shao

    Journal: AIDS Research and Therapy, 2014, Vol.11, 36, DOI:10.1186/1742-6405-11-36

  • The prevalence of transmitted HIV drug resistance among MSM in Anhui province, China

    Author: Yuelan Shen, Bin Su, Jianjun Wu, Yizu Qin, Lin Jin, Lifeng Miao, Aiwen Liu, Xiaoli Cheng

    Journal: AIDS Research and Therapy, 2014, Vol.11, 19, DOI:10.1186/1742-6405-11-19